Tuberculosis Therapy
Genetic Analysis May Not Be Sufficient For Drug-Resistance Testing
Published in Gene Therapy Weekly, October 11th, 2001
"The use of pyrazinamide (PZA) is important for the treatment of Mycobacterium tuberculosis as it is bactericidal to semi-dormant mycobacteria that are not affected by other drugs," explained K.S. Bishop and colleagues at the University of Natal in Durban and the SAIMR Tuberculosis Reference Laboratory in Gauteng. However, "incidence of resistance to PZA and other drugs used in the treatment of M. tuberculosis is increasing in South Africa."
Although genetic...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2001-10-11)
More Articles from Gene Therapy Weekly
- Autoimmunity
Plasmid DNA Injections May Cause Adverse Effects In Susceptible Groups - Gene Vectors
Therapy Containing Natural Inhibitor Controls Breast Cancer Metastasis - Blindness
Gene Therapy May Be A Tool For Prevention - Cancer Therapy
Immunological Gene Therapy And Tumor Debulking Delays Mesothelioma Growth - Immunization
Bystander Effect Seen After Vector Administration - Tumor Therapy
Antisense Strategy Dampens Angiogenesis, Promotes Apoptosis In Neoplasms - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
